首页> 外文期刊>Health >Impact of Bar-Code Medication Administration and Electronic Medication Administration Record System in Clinical Practice for an Effective Medication Administration Process
【24h】

Impact of Bar-Code Medication Administration and Electronic Medication Administration Record System in Clinical Practice for an Effective Medication Administration Process

机译:条形码药物管理和电子药物管理记录系统在临床实践中对有效药物管理过程的影响

获取原文
           

摘要

Clinical innovations are ideations resulting from collective experiences that enhance the “norm” and embrace an avenue for change with an invention. As such, collective data that were suggestive of increased medication errors that compromised patient safety initiated the exploration of methods that could reduce multifactorial human errors. The pursuit for an appropriate system followed with the discovery of barcode medication administration system (BCMA) and electronic medication administration system (e-MAR). Prior to the adoption of BCMA and e-MAR, it was crucial to assess the impact of the new medication administration system and the rate of medication administration errors recorded, specifically those that resulted in harm. The purpose of the study was to evaluate BCMA and e-MAR usage outcomes, clinical practices, policies, and processes impacting nurses administering medications in the clinical environment using BCMA and e-MAR system. Thus, an annotated literature review was conducted prior to the implementation of the innovation which analyzed various studies that elaborated on their study methods, data collection and analysis that deliberated on the advantages and disadvantages of barcode medication administration system. It is evident in the researched journals that increased compliance was observed with appropriate guidance, processes and policies in place. There was also a significant reduction in reported errors. The incorporation of barcode technology with electronic medication administration record (e-MAR) had greatly improved the efficiency of the BCMA system. BCMAs method was one of the proposed solutions to medication administration errors and to enhance patient safety measures. As such, the innovation could significantly reduce medication error resulting from intrinsic and extrinsic factors. This paper will further elaborate on the advantages and disadvantages of BCMA and e-MAR, the strategies assumed in the development of BCMA and e-MAR system and its implementation process by identifying and overcoming potential challenges that may arise.
机译:临床创新是源自集体经验的思想,这些经验可以增强“规范”并为发明提供改变的途径。因此,提示药物错误增加而损害患者安全性的集体数据开始探索可以减少多因素人为错误的方法。在寻找合适的系统之后,又发现了条形码药物管理系统(BCMA)和电子药物管理系统(e-MAR)。在采用BCMA和e-MAR之前,至关重要的是评估新药物管理系统的影响以及所记录的药物管理错误率,特别是那些导致伤害的错误。这项研究的目的是评估BCMA和e-MAR的使用结果,临床实践,政策和程序,这些影响在临床环境中使用BCMA和e-MAR系统的护士对药物管理的影响。因此,在实施本发明之前进行了带注释的文献综述,该文献分析了详细研究其研究方法,数据收集和分析的各种研究,这些研究探讨了条形码药物管理系统的优缺点。在所研究的期刊中,很明显的是,在适当的指导,流程和政策下,法规遵从性得到了提高。报告的错误也大大减少了。条形码技术与电子药物管理记录(e-MAR)的结合极大地提高了BCMA系统的效率。 BCMAs方法是针对药物管理错误和增强患者安全性措施提出的解决方案之一。这样,该创新可以显着减少由内在和外在因素引起的用药错误。本文将通过识别和克服可能出现的挑战,进一步详细阐述BCMA和e-MAR的优缺点,在BCMA和e-MAR系统的开发中假定的策略及其实施过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号